Role of Cholesterol as a Risk Factor in Cardiovascular Diseases
Author:
Publisher
InTech
Link
http://www.intechopen.com/download/pdf/61333
Reference38 articles.
1. Glagov S et al. Compensatory enlargement of human atherosclerotic coronary arteries. New England Journal of Medicine. 1987;316(22):1371-1375
2. Nicholls SJ et al. Effects of obesity on lipid-lowering, anti-inflammatory, and antiatherosclerotic benefits of atorvastatin or pravastatin in patients with coronary artery disease (from the REVERSAL Study). The American Journal of Cardiology. 2006;97(11):1553-1557
3. Kenneth C-W, John CL. Chylomicron-remnant-induced foam cell formation and cytotoxicity: A possible mechanism of cell death in atherosclerosis. Clinical Science. 2000;98(2):183-192
4. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian simvastatin survival study (4S). The Lancet. 1994;344(8934):1383-1389
5. Wiviott SD et al. Safety and efficacy of achieving very low low-density lipoprotein cholesterol levels with rosuvastatin 40 mg daily (from the ASTEROID study). The American Journal of Cardiology. 2009;104(1):29-35
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Hive-shaped carbon nanotubes coated with MoSe2 as an electrochemical sensor for cholesterol;Nanotechnology;2024-09-02
2. Dyslipidemia and associated factors among adult cardiac patients: a hospital-based comparative cross-sectional study;European Journal of Medical Research;2024-04-15
3. Re‐evaluation of the risks to public health related to the presence of bisphenol A (BPA) in foodstuffs;EFSA Journal;2023-04
4. Bioinformatics and System Biological Approaches for the Identification of Genetic Risk Factors in the Progression of Cardiovascular Disease;Cardiovascular Therapeutics;2022-08-09
5. Dispositional gratitude, health-related factors, and lipid profiles in midlife: a biomarker study;Scientific Reports;2022-04-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3